table of content
1 Introduction to Research & Analysis Reports
1.1 Biologic Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biologic Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biologic Drugs Overall Market Size
2.1 Global Biologic Drugs Market Size: 2022 VS 2032
2.2 Global Biologic Drugs Revenue, Prospects & Forecasts: 2018-2032
2.3 Global Biologic Drugs Sales: 2018-2032
3 Company Landscape
3.1 Top Biologic Drugs Players in Global Market
3.2 Top Global Biologic Drugs Companies Ranked by Revenue
3.3 Global Biologic Drugs Revenue by Companies
3.4 Global Biologic Drugs Sales by Companies
3.5 Global Biologic Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Biologic Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Biologic Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Biologic Drugs Players in Global Market
3.8.1 List of Global Tier 1 Biologic Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Biologic Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Biologic Drugs Market Size Markets, 2022 & 2032
4.1.2 Humira
4.1.3 Remicade
4.1.4 Rituxan
4.1.5 Enbrel
4.1.6 Lantus
4.1.7 Avastin
4.1.8 Herceptin
4.1.9 Others
4.2 By Type - Global Biologic Drugs Revenue & Forecasts
4.2.1 By Type - Global Biologic Drugs Revenue, 2018-2023
4.2.2 By Type - Global Biologic Drugs Revenue, 2024-2032
4.2.3 By Type - Global Biologic Drugs Revenue Market Share, 2018-2032
4.3 By Type - Global Biologic Drugs Sales & Forecasts
4.3.1 By Type - Global Biologic Drugs Sales, 2018-2023
4.3.2 By Type - Global Biologic Drugs Sales, 2024-2032
4.3.3 By Type - Global Biologic Drugs Sales Market Share, 2018-2032
4.4 By Type - Global Biologic Drugs Price (Manufacturers Selling Prices), 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Biologic Drugs Market Size, 2022 & 2032
5.1.2 Diabetes
5.1.3 Inflammation
5.1.4 Auto-Immune Diseases
5.1.5 Blood Diseases
5.1.6 Cardiovascular Diseases
5.1.7 Others
5.2 By Application - Global Biologic Drugs Revenue & Forecasts
5.2.1 By Application - Global Biologic Drugs Revenue, 2018-2023
5.2.2 By Application - Global Biologic Drugs Revenue, 2024-2032
5.2.3 By Application - Global Biologic Drugs Revenue Market Share, 2018-2032
5.3 By Application - Global Biologic Drugs Sales & Forecasts
5.3.1 By Application - Global Biologic Drugs Sales, 2018-2023
5.3.2 By Application - Global Biologic Drugs Sales, 2024-2032
5.3.3 By Application - Global Biologic Drugs Sales Market Share, 2018-2032
5.4 By Application - Global Biologic Drugs Price (Manufacturers Selling Prices), 2018-2032
6 Sights by Region
6.1 By Region - Global Biologic Drugs Market Size, 2022 & 2032
6.2 By Region - Global Biologic Drugs Revenue & Forecasts
6.2.1 By Region - Global Biologic Drugs Revenue, 2018-2023
6.2.2 By Region - Global Biologic Drugs Revenue, 2024-2032
6.2.3 By Region - Global Biologic Drugs Revenue Market Share, 2018-2032
6.3 By Region - Global Biologic Drugs Sales & Forecasts
6.3.1 By Region - Global Biologic Drugs Sales, 2018-2023
6.3.2 By Region - Global Biologic Drugs Sales, 2024-2032
6.3.3 By Region - Global Biologic Drugs Sales Market Share, 2018-2032
6.4 North America
6.4.1 By Country - North America Biologic Drugs Revenue, 2018-2032
6.4.2 By Country - North America Biologic Drugs Sales, 2018-2032
6.4.3 US Biologic Drugs Market Size, 2018-2032
6.4.4 Canada Biologic Drugs Market Size, 2018-2032
6.4.5 Mexico Biologic Drugs Market Size, 2018-2032
6.5 Europe
6.5.1 By Country - Europe Biologic Drugs Revenue, 2018-2032
6.5.2 By Country - Europe Biologic Drugs Sales, 2018-2032
6.5.3 Germany Biologic Drugs Market Size, 2018-2032
6.5.4 France Biologic Drugs Market Size, 2018-2032
6.5.5 U.K. Biologic Drugs Market Size, 2018-2032
6.5.6 Italy Biologic Drugs Market Size, 2018-2032
6.5.7 Russia Biologic Drugs Market Size, 2018-2032
6.5.8 Nordic Countries Biologic Drugs Market Size, 2018-2032
6.5.9 Benelux Biologic Drugs Market Size, 2018-2032
6.6 Asia
6.6.1 By Region - Asia Biologic Drugs Revenue, 2018-2032
6.6.2 By Region - Asia Biologic Drugs Sales, 2018-2032
6.6.3 China Biologic Drugs Market Size, 2018-2032
6.6.4 Japan Biologic Drugs Market Size, 2018-2032
6.6.5 South Korea Biologic Drugs Market Size, 2018-2032
6.6.6 Southeast Asia Biologic Drugs Market Size, 2018-2032
6.6.7 India Biologic Drugs Market Size, 2018-2032
6.7 South America
6.7.1 By Country - South America Biologic Drugs Revenue, 2018-2032
6.7.2 By Country - South America Biologic Drugs Sales, 2018-2032
6.7.3 Brazil Biologic Drugs Market Size, 2018-2032
6.7.4 Argentina Biologic Drugs Market Size, 2018-2032
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Biologic Drugs Revenue, 2018-2032
6.8.2 By Country - Middle East & Africa Biologic Drugs Sales, 2018-2032
6.8.3 Turkey Biologic Drugs Market Size, 2018-2032
6.8.4 Israel Biologic Drugs Market Size, 2018-2032
6.8.5 Saudi Arabia Biologic Drugs Market Size, 2018-2032
6.8.6 UAE Biologic Drugs Market Size, 2018-2032
7 Manufacturers & Brands Profiles
7.1 Roche
7.1.1 Roche Company Summary
7.1.2 Roche Business Overview
7.1.3 Roche Biologic Drugs Major Product Offerings
7.1.4 Roche Biologic Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Roche Key News & Latest Developments
7.2 Abbott Laboratories
7.2.1 Abbott Laboratories Company Summary
7.2.2 Abbott Laboratories Business Overview
7.2.3 Abbott Laboratories Biologic Drugs Major Product Offerings
7.2.4 Abbott Laboratories Biologic Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Abbott Laboratories Key News & Latest Developments
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Company Summary
7.3.2 Johnson & Johnson Business Overview
7.3.3 Johnson & Johnson Biologic Drugs Major Product Offerings
7.3.4 Johnson & Johnson Biologic Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Johnson & Johnson Key News & Latest Developments
7.4 Merck & Co.
7.4.1 Merck & Co. Company Summary
7.4.2 Merck & Co. Business Overview
7.4.3 Merck & Co. Biologic Drugs Major Product Offerings
7.4.4 Merck & Co. Biologic Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Merck & Co. Key News & Latest Developments
7.5 Pfizer
7.5.1 Pfizer Company Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Biologic Drugs Major Product Offerings
7.5.4 Pfizer Biologic Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Pfizer Key News & Latest Developments
7.6 Amgen
7.6.1 Amgen Company Summary
7.6.2 Amgen Business Overview
7.6.3 Amgen Biologic Drugs Major Product Offerings
7.6.4 Amgen Biologic Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Amgen Key News & Latest Developments
7.7 Sanofi
7.7.1 Sanofi Company Summary
7.7.2 Sanofi Business Overview
7.7.3 Sanofi Biologic Drugs Major Product Offerings
7.7.4 Sanofi Biologic Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Sanofi Key News & Latest Developments
7.8 Novartis
7.8.1 Novartis Company Summary
7.8.2 Novartis Business Overview
7.8.3 Novartis Biologic Drugs Major Product Offerings
7.8.4 Novartis Biologic Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Novartis Key News & Latest Developments
7.9 Eli Lilly
7.9.1 Eli Lilly Company Summary
7.9.2 Eli Lilly Business Overview
7.9.3 Eli Lilly Biologic Drugs Major Product Offerings
7.9.4 Eli Lilly Biologic Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Eli Lilly Key News & Latest Developments
7.10 Amgen
7.10.1 Amgen Company Summary
7.10.2 Amgen Business Overview
7.10.3 Amgen Biologic Drugs Major Product Offerings
7.10.4 Amgen Biologic Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Amgen Key News & Latest Developments
8 Global Biologic Drugs Production Capacity, Analysis
8.1 Global Biologic Drugs Production Capacity, 2018-2032
8.2 Biologic Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Biologic Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Biologic Drugs Supply Chain Analysis
10.1 Biologic Drugs Industry Value Chain
10.2 Biologic Drugs Upstream Market
10.3 Biologic Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Biologic Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
